» Articles » PMID: 19716778

Infection, Inflammation, and the Irritable Bowel Syndrome

Overview
Journal Dig Liver Dis
Publisher Elsevier
Specialty Gastroenterology
Date 2009 Sep 1
PMID 19716778
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Gastrointestinal infection is ubiquitous worldwide though the pattern of infection varies widely. Poor hygiene and lack of piped water is associated with a high incidence of childhood infection, both viral and bacterial. However in developed countries bacterial infection is commoner in young adults. Studies of bacterial infections in developed countries suggest 75% of adults fully recover, however around 25% have long lasting changes in bowel habit and a smaller number develop the irritable bowel syndrome (IBS). Whether the incidence is similar in developing countries is unknown. Post-infective IBS (PI-IBS) shares many features with unselected IBS but by having a defined onset allows better definition of risk factors. These are in order of importance: severity of initial illness, smoking, female gender and adverse psychological factors. Symptoms may last many years for reasons which are unclear. They are likely to include genetic factors controlling the immune response, alterations in serotonin signaling, low grade mucosal inflammation maintained by psychological stressors and alterations in gut microbiota. As yet there are no proven specific treatments, though 5HT(3) receptor antagonists, anti-inflammatory agents and probiotics are all logical treatments which should be examined in large well-designed randomised placebo controlled trials.

Citing Articles

Exploring Gut Microbiota Imbalance in Irritable Bowel Syndrome: Potential Therapeutic Effects of Probiotics and Their Metabolites.

Garcia Mansilla M, Rodriguez Sojo M, Lista A, Ayala Mosqueda C, Ruiz Malagon A, Galvez J Nutrients. 2025; 17(1.

PMID: 39796588 PMC: 11723002. DOI: 10.3390/nu17010155.


Diarrhea-predominant Irritable Bowel Syndrome-like Symptoms in Patients With Quiescent Crohn's Disease: Comprehensive Analysis of Clinical Features and Intestinal Environment Including the Gut Microbiome, Organic Acids, and Intestinal Permeability.

Tomita T, Fukui H, Morishita D, Maeda A, Makizaki Y, Tanaka Y J Neurogastroenterol Motil. 2023; 29(1):102-112.

PMID: 36606441 PMC: 9837540. DOI: 10.5056/jnm22027.


Gut Non-Bacterial Microbiota: Emerging Link to Irritable Bowel Syndrome.

Liu A, Gao W, Zhu Y, Hou X, Chu H Toxins (Basel). 2022; 14(9).

PMID: 36136534 PMC: 9503233. DOI: 10.3390/toxins14090596.


Mammary tumors alter the fecal bacteriome and permit enteric bacterial translocation.

Loman B, Russart K, Grant C, Lynch A, Bailey M, Pyter L BMC Cancer. 2022; 22(1):245.

PMID: 35248004 PMC: 8897840. DOI: 10.1186/s12885-022-09274-0.


Influence of Prebiotic Activity of Fructans on Mucus Production and Morphology Changes in Colonic Epithelium Cell of Healthy Wistar Rats.

Castillo Andrade A, Garcia Chavez E, Rivera Bautista C, Ovalle C, Ruiz Cabrera M, Grajales Lagunes A Front Plant Sci. 2021; 12:717460.

PMID: 34966396 PMC: 8710659. DOI: 10.3389/fpls.2021.717460.